NCI Dictionary of Cancer Terms
The search textbox has an autosuggest feature. When you enter three or more characters, a list of up to 10 suggestions will popup under the textbox. Use the arrow keys to move through the suggestions. To select a suggestion, hit the enter key. Using the escape key closes the listbox and puts you back at the textbox. The radio buttons allow you to toggle between having all search items start with or contain the text you entered in the search box.
A drug used to prevent or treat certain bone problems. Under the brand name Xgeva, it is used to prevent broken bones and other bone problems caused by solid tumors that have spread to bone. It is also used in certain patients to treat giant cell tumor of the bone that cannot be removed by surgery. Under the brand name Prolia, it is used to treat osteoporosis (a decrease in bone mass and density) in postmenopausal women who have a high risk of breaking bones. AMG 162 is also being studied in the treatment of other conditions and types of cancer. It binds to a protein called RANKL, which keeps RANKL from binding to another protein called RANK on the surface of certain bone cells, including bone cancer cells. This may help keep bone from breaking down and cancer cells from growing. AMG 162 is a type of monoclonal antibody. Also called denosumab, Prolia, and Xgeva.